GOLDMAN SACHS GROUP INC - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 60 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$274,356
+165.3%
46,344
+232.5%
0.00%
Q2 2023$103,427
-88.2%
13,939
-85.0%
0.00%
Q1 2023$879,937
+718.9%
93,115
+822.8%
0.00%
Q4 2022$107,459
+45.2%
10,090
+0.3%
0.00%
Q3 2022$74,00010,0550.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Interchange Capital Partners, LLC 11,420$90,0000.14%
GSA CAPITAL PARTNERS LLP 47,097$373,0000.04%
GOODWIN DANIEL L 10,000$80,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 99,166$784,0000.01%
EMFO, LLC 1,666$13,0000.01%
PINNACLE ASSOCIATES LTD 34,333$272,0000.01%
BLAIR WILLIAM & CO/IL 51,466$407,0000.00%
Tarbox Family Office, Inc. 332$3,0000.00%
Hartford Financial Management Inc. 598$5,0000.00%
Tower Research Capital LLC (TRC) 3,808$30,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders